IGF2BP1 was discovered to influence pancreatic cancer carcinogenesis by modifying the Akt signaling pathway, IGF2B2 by directly binding to and stabilizing GLUT1 mRNA, and IGF2B3 through regulating mRNA-miRNA interaction [26–28]. Here, AKT1 is linked to familial pancreatic carcinoma.